雙良節能(600481.SH)中標一期4萬噸高純晶硅項目還原爐項目
格隆匯1月18日丨雙良節能(600481.SH)公佈,公司近日收到雲南通威高純晶硅有限公司送達的《中標通知書》,確認公司中標《雲南通威高純晶硅有限公司一期4萬噸高純晶硅項目還原爐》招標項目,預計中標金額人民幣1.767億元。
該項目位於雲南省保山市工貿園區,總投資約40億元,主要從事高純晶硅的研發、生產和銷售等,預計2021年底建成投產。項目通過自動化、智能化的系統集成、大型節能型設備、熱能梯級利用、氯氫元素閉路循環、超低排放等領先技術,實現“低耗、高質”目標,滿足P型和N型單晶質量需求,部分達到電子級半導體硅材料質量標準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.